Global Pediatric Health (Feb 2021)

Antenatal Steroid Utilization in Ethiopia

  • Gesit Metaferia MD,
  • Mahlet Abayneh MD,
  • Sara Aynalem MD,
  • Abayneh G. Demisse MD,
  • Asrat G. Demtse MD,
  • Beza Eshetu MD,
  • Amha Mekasha MD,
  • Bogale Worku MD,
  • Assaye K. Nigussie MD,
  • Elizabeth M. McClure PHD,
  • Robert L. Goldenberg MD,
  • Lulu M. Muhe MD

DOI
https://doi.org/10.1177/2333794X21990344
Journal volume & issue
Vol. 8

Abstract

Read online

Background. Administration of antenatal corticosteroids to pregnant mothers is one of the most effective interventions to decrease preterm neonatal mortality. In this study we assessed antenatal steroid utilization by the mother and its effect on preterm babies. Method. Two years prospective, multicenter, observational study was conducted in selected hospitals of Ethiopia. Significance of the study outcomes was tested by chi-square and binary logistic regression. Result. Out of 4919 participants, 1575 preterm babies whose gestational ages were below 35 weeks were included in the study. Use of antenatal dexamethasone was 37.5% among study participants. The risk of early onset neonatal sepsis 235 (40.4%) was higher in preterm babies whose mother took antenatal dexamethasone ( P -value .002) than those who did not. Conclusion. Antenatal dexamethasone use in our study was comparable with other low and middle-income countries. Risk of early onset neonatal sepsis was higher among infants whose mother took antenatal dexamethasone.